Cargando…
Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
Tuberculosis (TB) remains a serious public health threat around the world. An effective vaccine is urgently required for cost-effective, long-term control of TB. However, the only licensed vaccine Bacillus Calmette-Guerin (BCG) is limited to prevent TB for its highly variable efficacy. Substantial p...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652786/ https://www.ncbi.nlm.nih.gov/pubmed/38022657 http://dx.doi.org/10.3389/fimmu.2023.1238649 |